Scilex Holding Co SEC filings SCLXW

Scilex Holding Co has 742 filings in SEC EDGAR's recent list, going back to Aug 19, 2020. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 29, 2026 (material agreement). The company's fiscal year ends on December 31.

Scilex Holding Co SEC filings
Form Description Filed Period
8-K Current report
Material agreement
Sep 29, 2026 Sep 25, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Aug 24, 2026 —
4 Insider transaction Aug 24, 2026 Aug 20, 2026
10-Q Quarterly report Aug 14, 2026 Jun 30, 2026
8-K Current report
Material agreement
Aug 12, 2026 Aug 8, 2026
8-K Current report
Material agreement, Acquisition or sale of assets
Jul 22, 2026 Jul 18, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Jul 7, 2026 —
4 Insider transaction Jul 7, 2026 Jul 3, 2026
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Jul 6, 2026 Jul 3, 2026
S-8 Employee stock plan registration Jun 30, 2026 —
8-K Current report
Material agreement, Unregistered share sale
Jun 29, 2026 Jun 24, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Jun 26, 2026 —
4 Insider transaction Jun 26, 2026 Jun 15, 2026
8-K Current report
Shareholder vote results
Jun 24, 2026 Jun 24, 2026
EFFECT Filing Jun 11, 2026 —
CORRESP Letter to the SEC Jun 9, 2026 —
UPLOAD Letter from the SEC Jun 9, 2026 —
S-3 Shelf registration Jun 2, 2026 —
EFFECT Filing May 22, 2026 —
10-Q Quarterly report May 20, 2026 Mar 31, 2026
CORRESP Letter to the SEC May 20, 2026 —
NT 10-Q Filing May 15, 2026 Mar 31, 2026
8-K Current report
Other events
May 11, 2026 May 11, 2026
DEFA14A Additional proxy material May 5, 2026 —
8-K Current report
Material agreement, Regulation FD disclosure
May 5, 2026 May 4, 2026
ARS Annual report to shareholders Apr 30, 2026 Dec 31, 2025
DEF 14A Proxy statement Apr 30, 2026 Jun 24, 2026
CORRESP Letter to the SEC Apr 30, 2026 —
8-K Current report
Material agreement
Apr 28, 2026 Apr 26, 2026
UPLOAD Letter from the SEC Apr 24, 2026 —
4 Insider transaction Apr 20, 2026 Apr 17, 2026
4 Insider transaction Apr 20, 2026 Apr 16, 2026
S-3 Shelf registration Apr 16, 2026 —
10-K Annual report Apr 10, 2026 Dec 31, 2025
NT 10-K Filing Apr 1, 2026 Dec 31, 2025
8-K Current report
Regulation FD disclosure
Mar 13, 2026 Mar 13, 2026
8-K Current report
Regulation FD disclosure
Mar 13, 2026 Mar 13, 2026
424B3 Prospectus Feb 23, 2026 —
424B3 Prospectus Feb 23, 2026 —
424B3 Prospectus Feb 23, 2026 —
8-K Current report
Material agreement, Unregistered share sale
Feb 20, 2026 Feb 19, 2026
UPLOAD Letter from the SEC Feb 20, 2026 —
DRS Filing Feb 13, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2026 —
S-8 Employee stock plan registration Feb 9, 2026 —
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Feb 3, 2026 Feb 2, 2026
8-K Current report
Material agreement
Feb 2, 2026 Jan 29, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Jan 14, 2026 —
4 Insider transaction Jan 14, 2026 Jan 12, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Jan 8, 2026 —
4 Insider transaction Jan 8, 2026 Jan 6, 2026
RW Filing Jan 6, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Dec 31, 2025 —
4/A Filing Dec 31, 2025 Dec 26, 2025
4 Insider transaction Dec 30, 2025 Dec 26, 2025
8-K Current report
Regulation FD disclosure
Dec 30, 2025 Dec 30, 2025
EFFECT Filing Dec 29, 2025 —
424B3 Prospectus Dec 29, 2025 —
CORRESP Letter to the SEC Dec 23, 2025 —
8-K Current report
Regulation FD disclosure
Dec 22, 2025 Dec 22, 2025
424B3 Prospectus Dec 17, 2025 —
424B3 Prospectus Dec 17, 2025 —
424B3 Prospectus Dec 17, 2025 —
8-K Current report
Material agreement, New debt
Dec 17, 2025 Dec 16, 2025
S-1 Registration statement Dec 16, 2025 —
424B3 Prospectus Dec 12, 2025 —
424B3 Prospectus Dec 12, 2025 —
424B3 Prospectus Dec 12, 2025 —
8-K Current report
Material agreement, New debt
Dec 12, 2025 Dec 8, 2025
424B3 Prospectus Dec 11, 2025 —
424B3 Prospectus Dec 11, 2025 —
424B3 Prospectus Dec 11, 2025 —
8-K Current report
Officer or director change, Shareholder vote results
Dec 11, 2025 Dec 11, 2025
424B3 Prospectus Dec 5, 2025 —
424B3 Prospectus Dec 5, 2025 —
424B3 Prospectus Dec 5, 2025 —
8-K Current report
Material agreement, New debt
Dec 5, 2025 Dec 1, 2025
UPLOAD Letter from the SEC Dec 4, 2025 —
SCHEDULE 13D Ownership over 5% (active) Dec 1, 2025 —
424B3 Prospectus Dec 1, 2025 —
424B3 Prospectus Dec 1, 2025 —
424B3 Prospectus Dec 1, 2025 —
8-K Current report
Acquisition or sale of assets, Regulation FD disclosure
Dec 1, 2025 Nov 25, 2025
4 Insider transaction Nov 28, 2025 Nov 25, 2025
3 Initial insider ownership Nov 28, 2025 Nov 25, 2025
424B3 Prospectus Nov 24, 2025 —
424B3 Prospectus Nov 24, 2025 —
424B3 Prospectus Nov 24, 2025 —
8-K Current report
Material agreement, Unregistered share sale
Nov 24, 2025 Nov 23, 2025
424B3 Prospectus Nov 14, 2025 —
424B3 Prospectus Nov 14, 2025 —
424B3 Prospectus Nov 14, 2025 —
10-Q Quarterly report Nov 14, 2025 Sep 30, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
DEF 14A Proxy statement Nov 7, 2025 Dec 11, 2025
424B3 Prospectus Nov 4, 2025 —
424B3 Prospectus Nov 4, 2025 —
424B3 Prospectus Nov 4, 2025 —
8-K Current report
Material agreement, Regulation FD disclosure
Nov 4, 2025 Nov 3, 2025
424B3 Prospectus Oct 31, 2025 —
424B3 Prospectus Oct 31, 2025 —
424B3 Prospectus Oct 31, 2025 —
8-K Current report
Agreement ended
Oct 31, 2025 Oct 30, 2025
PRE 14A Preliminary proxy statement Oct 28, 2025 Dec 11, 2025
D Filing Oct 14, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Oct 14, 2025 —
4 Insider transaction Oct 9, 2025 Oct 8, 2025
4 Insider transaction Oct 9, 2025 Oct 8, 2025
4 Insider transaction Oct 9, 2025 Oct 8, 2025
4 Insider transaction Oct 9, 2025 Oct 8, 2025
4 Insider transaction Oct 9, 2025 Oct 8, 2025
424B3 Prospectus Oct 7, 2025 —
424B3 Prospectus Oct 7, 2025 —
424B3 Prospectus Oct 7, 2025 —
8-K Current report
Officer or director change
Oct 7, 2025 Oct 1, 2025
SCHEDULE 13D Ownership over 5% (active) Oct 2, 2025 —
424B3 Prospectus Oct 2, 2025 —
424B3 Prospectus Oct 2, 2025 —
424B3 Prospectus Oct 2, 2025 —
8-K Current report
Material agreement, Unregistered share sale
Oct 1, 2025 Sep 30, 2025
424B3 Prospectus Sep 29, 2025 —
424B3 Prospectus Sep 29, 2025 —
424B3 Prospectus Sep 29, 2025 —
8-K Current report
Material agreement, Acquisition or sale of assets, Regulation FD disclosure
Sep 26, 2025 Sep 25, 2025
SCHEDULE 13D Ownership over 5% (active) Sep 26, 2025 —
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Regulation FD disclosure, Other events
Sep 26, 2025 Sep 23, 2025
8-K Current report
Officer or director change
Sep 26, 2025 Sep 22, 2025
4 Insider transaction Sep 25, 2025 Sep 23, 2025
3 Initial insider ownership Sep 23, 2025 Sep 22, 2025
CORRESP Letter to the SEC Aug 29, 2025 —
424B3 Prospectus Aug 21, 2025 —
424B3 Prospectus Aug 21, 2025 —
424B3 Prospectus Aug 21, 2025 —
8-K Current report
Officer or director change
Aug 21, 2025 Aug 16, 2025
UPLOAD Letter from the SEC Aug 20, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
424B3 Prospectus Aug 14, 2025 —
424B3 Prospectus Aug 14, 2025 —
424B3 Prospectus Aug 14, 2025 —
10-Q Quarterly report Aug 13, 2025 Jun 30, 2025
S-1 Registration statement Aug 4, 2025 —
424B3 Prospectus Jul 23, 2025 —
424B3 Prospectus Jul 23, 2025 —
424B3 Prospectus Jul 23, 2025 —
8-K Current report
Material agreement
Jul 23, 2025 Jul 22, 2025
8-K Current report
Material agreement, Unregistered share sale
Jul 23, 2025 Jul 22, 2025
424B3 Prospectus Jun 24, 2025 —
424B3 Prospectus Jun 24, 2025 —
424B3 Prospectus Jun 24, 2025 —
8-K Current report
Regulation FD disclosure
Jun 23, 2025 Jun 23, 2025
8-K Current report
Shareholder vote results
Jun 23, 2025 Jun 20, 2025
8-K Current report
Regulation FD disclosure
Jun 4, 2025 Jun 4, 2025
ARS Annual report to shareholders May 16, 2025 Dec 31, 2024
DEF 14A Proxy statement May 16, 2025 Jun 4, 2025
424B3 Prospectus May 15, 2025 —
424B3 Prospectus May 15, 2025 —
424B3 Prospectus May 15, 2025 —
10-Q Quarterly report May 14, 2025 Mar 31, 2025
424B3 Prospectus May 14, 2025 —
424B3 Prospectus May 14, 2025 —
424B3 Prospectus May 14, 2025 —
EFFECT Filing May 13, 2025 —
EFFECT Filing May 13, 2025 —
EFFECT Filing May 13, 2025 —
8-K Current report
Officer or director change
May 12, 2025 May 9, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 8, 2025 —
POS AM Filing May 7, 2025 —
POS AM Filing May 7, 2025 —
POS AM Filing May 7, 2025 —
8-K Current report
Other events
Apr 30, 2025 Apr 30, 2025
10-K/A Amended annual report Apr 29, 2025 Dec 31, 2024
8-K Current report
Regulation FD disclosure
Apr 22, 2025 Apr 22, 2025
8-K Current report
Material agreement
Apr 21, 2025 Apr 16, 2025
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Apr 15, 2025 Apr 14, 2025
8-K Current report
Regulation FD disclosure
Apr 11, 2025 Apr 11, 2025
S-8 Employee stock plan registration Apr 1, 2025 —
10-K Annual report Mar 31, 2025 Dec 31, 2024
424B3 Prospectus Mar 20, 2025 —
424B3 Prospectus Mar 20, 2025 —
8-K Current report
Shareholder vote results
Mar 20, 2025 Mar 19, 2025
8-K Current report
Regulation FD disclosure
Mar 10, 2025 Mar 10, 2025
424B3 Prospectus Mar 5, 2025 —
424B3 Prospectus Mar 3, 2025 —
424B3 Prospectus Mar 3, 2025 —
8-K Current report
Agreement ended
Mar 3, 2025 Feb 28, 2025
8-K Current report
Material agreement
Mar 3, 2025 Feb 28, 2025
424B3 Prospectus Feb 27, 2025 —
424B3 Prospectus Feb 27, 2025 —
DEF 14A Proxy statement Feb 27, 2025 Mar 19, 2025
8-K Current report
Material agreement
Feb 27, 2025 Feb 22, 2025
PRER14A Filing Feb 26, 2025 —
PRE 14A Preliminary proxy statement Feb 14, 2025 Mar 19, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Jan 23, 2025 —
4 Insider transaction Jan 23, 2025 Jan 21, 2025
424B3 Prospectus Jan 22, 2025 —
424B3 Prospectus Jan 22, 2025 —
8-K Current report
Material agreement, Regulation FD disclosure
Jan 22, 2025 Jan 21, 2025
424B3 Prospectus Jan 21, 2025 —
424B3 Prospectus Jan 21, 2025 —
8-K Current report
Other events
Jan 21, 2025 Jan 21, 2025

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
SCLX (Nasdaq), SCLXW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Palo Alto, CA
SEC filer status
, Emerging growth company
SEC CIK
1820190
Former names
Scilex Holding Company/DE (until Nov 30, 2022); Vickers Vantage Corp. I (until Nov 15, 2022)

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.